Episode Description
Dry eye disease (DED) is very common among adults; however, it is often undiagnosed and untreated. As DED can have a considerable impact on a patient’s quality of life, early diagnosis and treatment are essential. In this podcast, experts Marc R. Bloomenstein, OD, FAAO; Cory J. Lappin, OD, MS, FAAO; and Selina R. McGee, OD, FAAO, discuss the roles of ophthalmologists and optometrists in managing DED in an evolving treatment landscape, from screening and diagnosis to disease management.
Acknowledgment of Educational Grant Support
This activity is supported by an educational grant from Bausch + Lomb.
Marc R. Bloomenstein, OD, FAAO
Schwartz Laser Eye Center
Scottsdale, AZ
Disclosure: Consultant: AbbVie; Allergan Aesthetics; Astellas Pharma US; Azura Ophthalmics; Bausch + Lomb; Bruder Healthcare; Dompé US; LENZ Therapeutics; Ocuphire Pharma, Inc; OCuSOFT Inc; Olleyes; Reichert Technologies; Sight Sciences, Inc; STAAR Surgical Company; Sun Pharmaceutical Industries; Tarsus Pharmaceuticals, Inc; Théa Pharma; Topcon Healthcare; Viatris Inc; Visus Therapeutics, Inc. Speaker’s bureau: AbbVie; Allergan Aesthetics; Bausch + Lomb; Dompé US; Sight Sciences, Inc; STAAR Surgical Company; Viatris Inc.
Cory J. Lappin, OD, MS, FAAO
Founder
The Dry Eye Center of Ohio
Cincinnati, OH
Disclosure: Consultant: Alcon; Barti Software; CSI Dry Eye Software; Eyenovia; Lumenis Be, Inc; MYZE; Nordic Pharma, Inc; NORWOOD Device & Diagnostics; NuLids; PRN Vision Group; Rinsada; SCOPE Health Inc; Tarsus Pharmaceuticals; Viatris Inc; Vital Tears. Speaker’s bureau: Bausch + Lomb; Bruder Healthcare; Dompé US; Lumenis Be, Inc; M&S Technologies; Other: Barti Software (Investment); MYZE (Medical Advisory Board Member/Investment); NuLids (Investment).
Selina R. McGee, OD, FAAO
Visionary Founder/Owner
BeSpoke Vision
Adjunct Faculty NSUOCO
Past-President Intrepid Eye Society
Secretary/Treasurer Oklahoma Board of Examiners
Edmond, OK
Disclosure: Consultant: AbbVie; Aldeyra Therapeutics, Inc; Alcon; Amgen, Inc; Avellino Lab USA, Inc; Bausch + Lomb; Bruder Healthcare; Carl Zeiss Meditec; Cynosure and Hahn; Dompé US; KALA BIO, Inc; Lumenis Be, Inc; Optovue; RVL Pharmaceuticals, Inc; ScienceBased Health; Sun Pharmaceutical Industries; Tarsus Pharmaceuticals, Inc; Théa Pharma; Topcon Healthcare; Versant; Viatris Inc Health. Speaker’s bureau: AbbVie; Alcon; Bausch + Lomb; Cynosure and Hahn; Dompé US; Lumenis Be, Inc; Optovue; ScienceBased Health; Sun Pharmaceutical Industries; Tarsus Pharmaceuticals, Inc; Viatris Inc.
Faculty, Staff, and Planners’ Disclosures
In accordance with ACCME Guidelines, PER® has identified and resolved all conflict of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
This podcast was developed by PER® editorial staff based on an online activity developed with these faculty.